ALLMedicine™ Bacterial Vaginosis Center
Research & Reviews 2,133 results
https://doi.org/10.1080/01443615.2020.1867966
Journal of Obstetrics and Gynaecology : the Journal of Th... Antoni Vives J, Cancelo MJ et. al.
Feb 25th, 2021 - Bacterial vaginosis (BV) represents the most frequent vaginal infection in women of childbearing age. The aim of this study was to characterise episodes of BV among adult Spanish women and their management with dequalinium chloride (DQC). Data fro...
https://doi.org/10.3201/eid2703.201783
Emerging Infectious Diseases; Scoullar MJL, Boeuf P et. al.
Feb 24th, 2021 - Much about the range of pathogens, frequency of coinfection, and clinical effects of reproductive tract infections (RTIs) among pregnant women remains unknown. We report on RTIs (Mycoplasma genitalium, Chlamydia trachomatis, Neisseria gonorrhoeae,...
https://doi.org/10.1136/sextrans-2020-054740
Sexually Transmitted Infections; Garrett N, Mtshali A et. al.
Feb 20th, 2021 - STIs cause inflammation that is detrimental for both HIV risk and reproductive health. We assessed the impact of point-of-care (POC) STI testing, immediate treatment and expedited partner therapy (EPT) on genital tract cytokines among a cohort of ...
https://doi.org/10.1093/humrep/deab002
Human Reproduction (Oxford, England); Lokken EM, Manhart LE et. al.
Feb 17th, 2021 - Is bacterial vaginosis (BV) associated with fecundability? Women with BV may be at increased risk for sub-fecundity. While BV has been associated with poor IVF outcomes, the association between vaginal microbiota disruption and non-medically assis...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877752
PloS One; Plummer EL, Bradshaw CS et. al.
Feb 11th, 2021 - The vaginal microbiota in bacterial vaginosis (BV) typically has low abundance of lactic acid producing lactobacilli. Lactic acid has properties that may make it effective for treating BV and/or restoring an optimal lactobacillus-dominated vaginal...
Guidelines 13 results
https://doi.org/10.1001/jama.2020.2684
JAMA , Owens DK et. al.
Apr 7th, 2020 - Bacterial vaginosis is common and is caused by a disruption of the microbiological environment in the lower genital tract. In the US, reported prevalence of bacterial vaginosis among pregnant women ranges from 5.8% to 19.3% and is higher in some r...
https://www.uspreventiveservicestaskforce.org/Page/Document/draft-recommendation-statement/bacterial-vaginosis-in-pregnant-adolescents-and-women-to-prevent-preterm-delivery-screening
Oct 7th, 2019 - The USPSTF recommends against screening for bacterial vaginosis (BV) in pregnant persons who are not at increased risk for preterm delivery.
https://doi.org/10.1016/j.jogc.2017.04.018
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Yudin MH, Money DM
Jul 21st, 2017 - To review the evidence and provide recommendations on screening for and management of bacterial vaginosis in pregnancy. The clinical practice options considered in formulating the guideline. Outcomes evaluated include antibiotic treatment efficacy...
https://www.cdc.gov/std/tg2015/bv.htm
Jun 4th, 2015
https://doi.org/10.1016/S1701-2163(15)30316-9
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... van Schalkwyk J, Yudin MH et. al.
May 23rd, 2015 - To review the evidence and provide recommendations on screening for and management of vulvovaginal candidiasis, trichomoniasis, and bacterial vaginosis. OUTCOMES evaluated include the efficacy of antibiotic treatment, cure rates for simple and com...
Drugs 75 results see all →
Clinicaltrials.gov 2,285 results
https://doi.org/10.1080/01443615.2020.1867966
Journal of Obstetrics and Gynaecology : the Journal of Th... Antoni Vives J, Cancelo MJ et. al.
Feb 25th, 2021 - Bacterial vaginosis (BV) represents the most frequent vaginal infection in women of childbearing age. The aim of this study was to characterise episodes of BV among adult Spanish women and their management with dequalinium chloride (DQC). Data fro...
https://doi.org/10.3201/eid2703.201783
Emerging Infectious Diseases; Scoullar MJL, Boeuf P et. al.
Feb 24th, 2021 - Much about the range of pathogens, frequency of coinfection, and clinical effects of reproductive tract infections (RTIs) among pregnant women remains unknown. We report on RTIs (Mycoplasma genitalium, Chlamydia trachomatis, Neisseria gonorrhoeae,...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d96a410e-c799-42f3-afcc-3a330faa4b63
Feb 21st, 2021 - Metronidazole vaginal gel USP, 0.75% is indicated in the treatment of bacterial vaginosis (formerly referred to as Haemophilus vaginitis, Gardnerella vaginitis, nonspecific vaginitis, Corynebacterium vaginitis, or anaerobic vaginosis). NOTE: For p...
https://doi.org/10.1136/sextrans-2020-054740
Sexually Transmitted Infections; Garrett N, Mtshali A et. al.
Feb 20th, 2021 - STIs cause inflammation that is detrimental for both HIV risk and reproductive health. We assessed the impact of point-of-care (POC) STI testing, immediate treatment and expedited partner therapy (EPT) on genital tract cytokines among a cohort of ...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8eff89b6-ff2b-ba3c-e053-2995a90aaff2
Feb 18th, 2021 - Metronidazole vaginal gel USP, 0.75% is indicated in the treatment of bacterial vaginosis (formerly referred to as Haemophilus vaginitis, Gardnerella vaginitis, nonspecific vaginitis, Corynebacterium vaginitis, or anaerobic vaginosis). NOTE: For p...
News 147 results
https://www.medscape.com/viewarticle/943221
Dec 28th, 2020 - NEW YORK (Reuters Health) - Vaginal microbes associated with bacterial vaginosis (BV) metabolize drugs used in HIV pre-exposure prophylaxis (PrEP) at different rates, which could explain why PrEP is less effective in women than in men, new finding...
https://www.staging.medscape.com/viewarticle/938232
Sep 28th, 2020 - Limited data are available to guide treatment of recurrent bacterial vaginosis, but behavioral changes and switching between approved medication regimens may help, according to a presenter at the virtual conference on diseases of the vulva and vag...
https://www.medscape.com/viewarticle/938232
Sep 28th, 2020 - Limited data are available to guide treatment of recurrent bacterial vaginosis, but behavioral changes and switching between approved medication regimens may help, according to a presenter at the virtual conference on diseases of the vulva and vag...
https://www.mdedge.com/obgyn/article/219749/gynecologic-cancer/vaginal-artesunate-quells-cin-2/3-lesions-clears-hpv/page/0/1?channel=53
Mar 29th, 2020 - Safety and next steps The safety analysis showed that side effects were generally mild and well tolerated. There were 161 adverse events among 29 women for whom safety data were available.
https://www.medpagetoday.com/obgyn/pregnancy/82631
Oct 8th, 2019 - Insufficient evidence exists to recommend routine screening for pregnant women at higher risk of preterm birth for bacterial vaginosis, the U.S. Preventive Services Task Force (USPSTF) said. There was not enough evidence to determine the benefits ...